Book a demo
Book a live 1:1 demo with one of our expert.
Trusted by 200+ Clients Worldwide
7 500+ Clinical Trials
Simplified Clinical Trial Management
100% Compliant and Secure Solution
A Complete and Agile Platform






"We started with limited experience in digital data management. With Datacapt, everything was clear, smooth, fast."

Entia is a London-based MedTech company specializing in at-home monitoring solutions for patients. With its Liberty technology, Entia has created the world’s first at-home blood monitoring system for cancer patients. Liberty enables patients to self-test and monitor their health remotely from the comfort of home, by just a simple finger-prick sample, while transmitting results directly to their healthcare team.
Driven by continuous innovation, Entia aims to improve access to care and streamline the patient journey. The company is rapidly growing, with clinical trials conducted in both the UK and the US, in a demanding regulatory environment. Quality, compliance, and ease of use are at the core of its technological approach.
Embarking on an international clinical program, Entia needed to quickly structure its data management to meet GCP requirements and prepare for regulatory submissions in the US.
Its first studies were launched in the UK with several hospital sites involved. The limitations of paper, and later Excel, became quickly apparent: duplicate files, data entry errors, lack of traceability, and the inability to collaborate efficiently with site teams.
With limited digital study data management experience within the team, Entia still required an upgrade to their system. An EDC solution was necessary but most available options felt too complex, too rigid, or unsuitable for a resource-constrained startup.
This is when Entia discovered Datacapt.

With more than 100 patients recruited in under two months, and multiple medical devices requiring individual tracking (lot numbers, IDs, timestamps), Entia could no longer rely on Excel files or manual transfers between teams.
Google Sheets was immediately ruled out: UK hospitals (NHS) blocked access to Google Workspace, making any cloud-based sharing impossible with sites. The lack of versioning, validation, audit trail, and centralization also stood in the way of progress.
For Madeline, the need was twofold: find a tool simple enough to learn quickly, yet structured enough to ensure data quality all without depending on external consultants or technical support.

Entia chose Datacapt to run its studies independently. From day one, the Entia team was able to design and test forms directly in the interface, no coding required.
Datacapt rapidly became the collaborative hub between Entia and its investigation sites. Users could access data in real time, track patient progress, and resolve queries from anywhere in the world.
The platform also provided unmatched flexibility: forms could be updated with every protocol iteration without relying on external system experts. Exports were instant, and every action was traceable.
In just a few weeks, Entia transitioned from outdated, manual methods to smooth, secure, and GCP-compliant data management.
The benefits
Datacapt allowed Entia’s team to boost efficiency from the very first studies.
Ease of use was praised by sites themselves, who compared Datacapt favorably against far more complex and less intuitive systems.


Entia proved that it is possible to run complex multicenter trials across two demanding regulatory environments without a dedicated data management team.
With Datacapt, the company gained agility, shortened timelines, improved data quality, and laid the foundations for international growth.
The platform became more than just an EDC; it turned into a shared workspace for both sponsor and sites.
Today, Entia continues to rely on Datacapt for all ongoing UK and US studies.
